1. Home
  2. ARVN vs JACK Comparison

ARVN vs JACK Comparison

Compare ARVN & JACK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • JACK
  • Stock Information
  • Founded
  • ARVN 2015
  • JACK 1951
  • Country
  • ARVN United States
  • JACK United States
  • Employees
  • ARVN N/A
  • JACK N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • JACK Restaurants
  • Sector
  • ARVN Health Care
  • JACK Consumer Discretionary
  • Exchange
  • ARVN Nasdaq
  • JACK Nasdaq
  • Market Cap
  • ARVN 456.2M
  • JACK 373.1M
  • IPO Year
  • ARVN 2018
  • JACK 1987
  • Fundamental
  • Price
  • ARVN $6.79
  • JACK $16.67
  • Analyst Decision
  • ARVN Buy
  • JACK Hold
  • Analyst Count
  • ARVN 22
  • JACK 18
  • Target Price
  • ARVN $20.21
  • JACK $34.06
  • AVG Volume (30 Days)
  • ARVN 2.1M
  • JACK 961.2K
  • Earning Date
  • ARVN 08-06-2025
  • JACK 08-06-2025
  • Dividend Yield
  • ARVN N/A
  • JACK 10.56%
  • EPS Growth
  • ARVN N/A
  • JACK N/A
  • EPS
  • ARVN N/A
  • JACK N/A
  • Revenue
  • ARVN $372,800,000.00
  • JACK $1,488,411,000.00
  • Revenue This Year
  • ARVN $7.57
  • JACK N/A
  • Revenue Next Year
  • ARVN N/A
  • JACK N/A
  • P/E Ratio
  • ARVN N/A
  • JACK N/A
  • Revenue Growth
  • ARVN 299.57
  • JACK N/A
  • 52 Week Low
  • ARVN $5.90
  • JACK $16.63
  • 52 Week High
  • ARVN $29.61
  • JACK $56.29
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 41.59
  • JACK 31.99
  • Support Level
  • ARVN $6.06
  • JACK $18.93
  • Resistance Level
  • ARVN $7.83
  • JACK $19.78
  • Average True Range (ATR)
  • ARVN 0.40
  • JACK 1.15
  • MACD
  • ARVN -0.11
  • JACK -0.55
  • Stochastic Oscillator
  • ARVN 34.93
  • JACK 0.51

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About JACK Jack In The Box Inc.

Jack In The Box Inc operates quick-service restaurants and fast-casual restaurants across various states in the United States of America under the Jack in the Box and Del Taco brands. The company's menu offers burgers, tacos, regular and curly fries, specialty sandwiches, salads, and ice cream shakes. These foods are available with the option of customization as per customer requirements. The company also offers catering and delivery services to its customers. Jack in the Box and Del Taco restaurant brands are the two reportable operating segments, of which, Jack in the Box generates maximum revenue for the company.

Share on Social Networks: